Modena, Italy

Enrico Canini


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Enrico Canini: Innovator in Extracorporeal Blood Treatment Systems

Introduction

Enrico Canini is a notable inventor based in Modena, Italy. He has made significant contributions to the field of medical technology, particularly in the area of blood treatment systems. His innovative approach has led to advancements that enhance patient care and treatment efficiency.

Latest Patents

Enrico Canini holds a patent for a method designed to determine the recirculation of blood in a vascular access system. The patent, titled "Method for determining the recirculation of blood in a vascular access and a system for implementing same," outlines a process within an extracorporeal blood treatment system. This system allows for the withdrawal of non-treated blood from a patient through an arterial line connected to a blood treatment apparatus. The apparatus features a semi-permeable membrane that separates treated blood from non-treated blood. By adjusting the ultrafiltration rate of plasma water, Canini's method enables the determination of blood recirculation, which is crucial for optimizing treatment outcomes.

Career Highlights

Enrico Canini has dedicated his career to improving medical technologies. His work at Hospal AG has positioned him as a key player in the development of advanced blood treatment systems. His innovative methods have not only contributed to the efficiency of these systems but have also enhanced the safety and comfort of patients undergoing treatment.

Collaborations

Enrico has collaborated with esteemed colleagues such as Giovanni Paolo Cavicchioli and Massimo Fava. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further advancing the field of medical technology.

Conclusion

Enrico Canini's contributions to the field of extracorporeal blood treatment systems exemplify the impact of innovation in healthcare. His patented methods and collaborative efforts continue to influence the development of safer and more effective medical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…